ZYFLO (Chiesi USA, Inc.)


Welcome to the PulseAid listing for the ZYFLO drug offered from Chiesi USA, Inc.. This 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Chiesi USA, Inc.
NON-PROPRIETARY NAME: zileuton
SUBSTANCE NAME: ZILEUTON
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1996-12-06
END MARKETING DATE: 0000-00-00


ZYFLO HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZYFLO from Chiesi USA, Inc.
LABELER NAME: Chiesi USA, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 600(mg/1)
START MARKETING DATE: 1996-12-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10122-901_2ca0eba1-1472-455f-95d2-d96cf271565e
PRODUCT NDC: 10122-901
APPLICATION NUMBER: NDA020471

Other ZILEUTON Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Chiesi USA, Inc.ZYFLO
Prasco, LLCZileuton
Rising Pharmaceuticals, Inc.Zileuton